Literature DB >> 23771351

Awareness of chronic kidney disease in Austria: a frequently under-recognized clinical picture.

Claudia Friedl1, Margit Hemetsberger, Julia Mader, Astrid Fahrleitner-Pammer, Thomas R Pieber, Alexander R Rosenkranz.   

Abstract

BACKGROUND: The prevalence of chronic kidney disease (CKD) is rising at an alarming rate, thus presenting a substantial burden for the patient as an individual and-because of the enormous treatment costs-for society as a whole. Early diagnosis and therapy could slow disease progression and reduce the prevalence of cost-intensive end stage renal disease. The aim of this study was to determine the accuracy of diagnosis of CKD in acute patients presenting at an internal ward.
METHODS: Routine laboratory parameters of kidney function of 238 inpatients were retrospectively evaluated to determine the prevalence of CKD, defined as estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m(2). Those results were compared with the actual documentation of the ICD-10 diagnosis CKD in the discharge reports of the respective patients.
RESULTS: Of 238 patients, 228 patients were included in the analysis. The overall median (range) eGFR was 60.7 (10.4-171.9) mL/min/1.73 m(2), with no gender-specific difference. Of patients, 49.6 % (n = 113) were retrospectively diagnosed with CKD stage 3 or higher. However, the review of the discharge reports found correct diagnosis of CKD in only 38.1 % (n = 43) of these patients.
CONCLUSIONS: The present analysis shows that CKD remains frequently unrecognized, even in a hospital setting. This could have dramatic implications on the care, treatment and prevention of CKD and associated complications.

Entities:  

Mesh:

Year:  2013        PMID: 23771351     DOI: 10.1007/s00508-013-0374-7

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  30 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

Review 2.  The aging kidney.

Authors:  Xin J Zhou; Dinesh Rakheja; Xueqing Yu; Ramesh Saxena; Nosratola D Vaziri; Fred G Silva
Journal:  Kidney Int       Date:  2008-07-09       Impact factor: 10.612

Review 3.  Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.

Authors:  C Black; P Sharma; G Scotland; K McCullough; D McGurn; L Robertson; N Fluck; A MacLeod; P McNamee; G Prescott; C Smith
Journal:  Health Technol Assess       Date:  2010-04       Impact factor: 4.014

4.  Drug dosing consideration in patients with acute and chronic kidney disease-a clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Gary R Matzke; George R Aronoff; Arthur J Atkinson; William M Bennett; Brian S Decker; Kai-Uwe Eckardt; Thomas Golper; Darren W Grabe; Bertram Kasiske; Frieder Keller; Jan T Kielstein; Ravindra Mehta; Bruce A Mueller; Deborah A Pasko; Franz Schaefer; Domenic A Sica; Lesley A Inker; Jason G Umans; Patrick Murray
Journal:  Kidney Int       Date:  2011-09-14       Impact factor: 10.612

5.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

6.  Projecting the number of patients with end-stage renal disease in the United States to the year 2015.

Authors:  David T Gilbertson; Jiannong Liu; Jay L Xue; Thomas A Louis; Craig A Solid; James P Ebben; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2005-11-02       Impact factor: 10.121

7.  The validity of searching routinely collected general practice computer data to identify patients with chronic kidney disease (CKD): a manual review of 500 medical records.

Authors:  Sobana Anandarajah; Tracy Tai; Simon de Lusignan; Paul Stevens; Donal O'Donoghue; Mel Walker; Sean Hilton
Journal:  Nephrol Dial Transplant       Date:  2005-07-19       Impact factor: 5.992

8.  Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes.

Authors:  A S Levey; R Atkins; J Coresh; E P Cohen; A J Collins; K-U Eckardt; M E Nahas; B L Jaber; M Jadoul; A Levin; N R Powe; J Rossert; D C Wheeler; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2007-06-13       Impact factor: 10.612

9.  Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.

Authors:  Roberto Minutolo; Luca De Nicola; Giampiero Mazzaglia; Maurizio Postorino; Claudio Cricelli; Lorenzo G Mantovani; Giuseppe Conte; Bruno Cianciaruso
Journal:  Am J Kidney Dis       Date:  2008-05-12       Impact factor: 8.860

10.  Estimated GFR reporting is not sufficient to allow detection of chronic kidney disease in an Italian regional hospital.

Authors:  Giorgio Gentile; Maurizio Postorino; Raymond D Mooring; Luigi De Angelis; Valeria Maria Manfreda; Fabrizio Ruffini; Manuela Pioppo; Giuseppe Quintaliani
Journal:  BMC Nephrol       Date:  2009-09-01       Impact factor: 2.388

View more
  3 in total

1.  Independent correlates of chronic kidney disease awareness among adults with type 2 diabetes.

Authors:  Ndidiamaka O Obadan; Rebekah J Walker; Leonard E Egede
Journal:  J Diabetes Complications       Date:  2017-03-18       Impact factor: 2.852

2.  Efficacy, safety, and tolerability of antihypertensive therapy with aliskiren/amlodipine in clinical practice in Austria. The RALLY (Rasilamlo long lasting efficacy) study.

Authors:  Alexander R Rosenkranz; Michaela Ratzinger
Journal:  Wien Klin Wochenschr       Date:  2015-03-05       Impact factor: 1.704

3.  Cross-sectional study of diabetes kidney disease in the Eastern Cape, South Africa.

Authors:  Oladele Vincent Adeniyi; Eyitayo Omolara Owolabi
Journal:  Medicine (Baltimore)       Date:  2020-12-11       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.